Medicare Enrolled

Dr. Scott McShane, DO

Internal Medicine · Spokane, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
105 W 8TH AVE STE 6010, Spokane, WA 99204
5098385950
In practice since 2012 (14 years)
NPI: 1629330394 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McShane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McShane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McShane

Dr. Scott McShane is an internal medicine specialist in Spokane, WA, with 14 years of NPI registration. Based on federal Medicare data, Dr. McShane performed 2,698 Medicare services across 435 unique beneficiaries.

Between the years covered by Open Payments, Dr. McShane received a total of $4,095 from 29 pharmaceutical and/or device companies across 218 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McShane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 4% volume in WA $4,095 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,698
Medicare services
Top 4% in WA for internal medicine
435
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~193 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,240 $26 $105
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
97 $81 $600
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
97 $127 $790
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
79 $200 $890
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
35 $106 $370
Blood glucose level test
A test that measures the amount of sugar in your blood.
30 $4 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $88 $225
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
24 $116 $625
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
24 $23 $100
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
21 $162 $665
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
13 $179 $665
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $112 $340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
84.3% high complexity
9.3% medium
6.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,095
Total received (2018-2024)
Avg $585/year across 7 years
Top 13% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
218
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,961 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$135 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$992
2023
$753
2022
$360
2021
$135
2020
$127
2019
$957
2018
$772

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$344
Lilly USA, LLC
$162
Regeneron Healthcare Solutions, Inc.
$144
Takeda Pharmaceuticals U.S.A., Inc.
$85
Intercept Pharmaceuticals, Inc.
$46
Janssen Biotech, Inc.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
PFIZER INC.
$31
GENZYME CORPORATION
$24
Celgene Corporation
$22
Fresenius Kabi USA, LLC
$20
Ferring Pharmaceuticals Inc.
$19
Braintree Laboratories, Inc.
$15
Ardelyx, Inc.
$15
Top 3 companies account for 65.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$617
AbbVie, Inc.
$517
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$485
Janssen Biotech, Inc.
$453
Regeneron Healthcare Solutions, Inc.
$252
Takeda Pharmaceuticals U.S.A., Inc.
$229
Lilly USA, LLC
$219
Celgene Corporation
$148
Merck Sharp & Dohme Corporation
$118
PFIZER INC.
$111
UCB, Inc.
$105
Janssen Scientific Affairs, LLC
$97
Braintree Laboratories, Inc.
$92
GENZYME CORPORATION
$82
Fresenius Kabi USA, LLC
$75
Gilead Sciences, Inc.
$73
Endo Pharmaceuticals Inc.
$67
Intercept Pharmaceuticals, Inc.
$62
Ferring Pharmaceuticals Inc.
$52
Ardelyx, Inc.
$48
Shionogi Inc
$37
AbbVie Inc.
$30
TerSera Therapeutics LLC
$28
Daiichi Sankyo Inc.
$20
Amgen Inc.
$20
Janssen Pharmaceuticals, Inc
$17
Exact Sciences Corporation
$16
Shire North American Group Inc
$16
Merck Sharp & Dohme LLC
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
APRISO · AVSOLA · CIMZIA · CREON · CYRAMZA · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · GATTEX · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · LINZESS · MAVYRET · Mavyret · Mulpleta · NASCOBAL · OCALIVA · OMVOH · REBYOTA · RINVOQ · SKYRIZI · STELARA · SUFLAVE · SUTAB · TREMFYA · UCERIS · UCERIS TABLETS · XARELTO · XELJANZ · XIFAXAN · Xermelo · ZEPATIER · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Spokane?
Compare internal medicine physicians in the Spokane area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
265
Per 100K population
48.7
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McShane is a mixed practice specialist, with above-average Medicare volume (top 4% in WA), with low-engagement industry engagement in the top 13% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McShane experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. McShane performed 2,240 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McShane receive payments from pharmaceutical companies?
Yes. Dr. McShane received a total of $4,095 from 29 companies across 218 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McShane's costs compare to other internal medicine physicians in Spokane?
Dr. McShane's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McShane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →